Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof
US8642545B2 · kind B2 · utility
0Cited by
6References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2008 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Dec 8, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is provided is EPO mimetic peptide derivatives defined as formula (I) and their pharmaceutical salts, the preparation thereof, wherein R1, R2, R3, R4, R5, n1, n2 are defined as described in description. A composition comprising of an EPO mimetic peptide derivative defined as formula (I) and its pharmaceutical salt. The uses of the derivatives and their pharmaceutical salts, as well as the uses of the compositions described above in treatment of diseases characterized by a deficiency of EPO or a low or defective red blood cell population.R1—R2—(CH2)n1—R3—(CH2)n2—R4—R5 (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.